NCT03550833

Brief Summary

Rheumatoid Arthritis (RA) is an inflammatory rheumatic disease that can lead to structural damage and handicap. The RA physiopathology is multifactorial, including genetic and environmental risk factors. The identification of environmental factors implication is crucial to understand the RA mechanism, and improves the diagnosis and the treatment of the disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
152

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2018

Geographic Reach
1 country

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 28, 2018

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 8, 2018

Completed
5 days until next milestone

Study Start

First participant enrolled

June 13, 2018

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 4, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 4, 2019

Completed
Last Updated

September 12, 2019

Status Verified

September 1, 2019

Enrollment Period

1.1 years

First QC Date

May 28, 2018

Last Update Submit

September 10, 2019

Conditions

Keywords

Rheumatoid arthritisStress

Outcome Measures

Primary Outcomes (1)

  • Life events calculated over the year preceding the onset of PR symptoms

    Social Readjustment Rating Scale (SRRS)

    At inclusion (day 0)

Secondary Outcomes (10)

  • Perceived stress

    At inclusion (day 0)

  • Perceived control

    At inclusion (day 0)

  • Perceived social support

    At inclusion (day 0)

  • State Anxiety

    At inclusion (day 0)

  • Coping

    At inclusion (day 0)

  • +5 more secondary outcomes

Study Arms (2)

Rheumatoid Arthritis patients

patients affected by RA according to ACR/EULAR 2010 criteria, with a disease duration less than 2 years

Behavioral: QuestionnaireBiological: blood sample

control patients

patients with a visceral surgery for less than 2 years (appendectomy, cholecystectomy, bowel obstruction, hernia, eventration…)

Behavioral: Questionnaire

Interventions

QuestionnaireBEHAVIORAL

Questionnaire

Rheumatoid Arthritis patientscontrol patients
blood sampleBIOLOGICAL

7 ml whole blood for Peripheral blood

Rheumatoid Arthritis patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients affected by RA according to ACR/EULAR 2010 criteria, with a disease duration less than 2 years

You may qualify if:

  • patients aged over 18 years old
  • patients affected by RA according to ACR/EULAR 2010 criteria, with a disease duration less than 2 years.
  • Speaking and understanding French language
  • Being informed about the study and having given his oral consent

You may not qualify if:

  • Pregnant or breastfeeding women
  • Patient who refuse to participate.
  • Control :
  • patients aged over 18 years old
  • patients with a visceral surgery for less than 2 years (appendectomy, cholecystectomy, bowel obstruction, hernia, eventration…)
  • Speaking and understanding French language
  • Being informed about the study and having given his oral consent
  • Pregnant or breastfeeding women
  • Patient who refuse to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

CHU de Bordeaux - service de rhumatologie

Bordeaux, France

Location

CH de Dax - service de rhumatologie

Dax, France

Location

Hôpital Suburbain du Bouscat

Le Bouscat, France

Location

CH de Libourne - service de rhumatologie

Libourne, France

Location

CH de Pau - service de rhumatologie

Pau, France

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

blood sample

MeSH Terms

Conditions

Arthritis, RheumatoidStress Disorders, Traumatic

Interventions

Surveys and QuestionnairesBlood Specimen Collection

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System DiseasesTrauma and Stressor Related DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public HealthSpecimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, Operative

Study Officials

  • Thierry SCHAEVERBEKE, Prof

    University Hospital, Bordeaux

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 28, 2018

First Posted

June 8, 2018

Study Start

June 13, 2018

Primary Completion

July 4, 2019

Study Completion

July 4, 2019

Last Updated

September 12, 2019

Record last verified: 2019-09

Locations